7 Results for "

Triflusal

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "Triflusal" in MCE Product Catalog:

Cat. No.: HY-B0531
CAS No.: 322-79-2
Triflusal is an orally bioavailable, blood-brain barrier-permeable dual Cyclooxygenase-1 (COX-1)/cAMP phosphodiesterase inhibitor. Triflusal inhibits platelet aggregation, NF-κB activation, iNOS activity, and prostaglandin synthesis in ischaemic tissue. Triflusal stimulates neutrophil nitric oxide production, eNOS protein expression, and cNOS activity. Triflusal alleviates cerebral ischemic injury in rats and ameliorates pathological lesions and related gene expression in transgenic Alzheimer’s disease models. Triflusal can be used for the research of thromboembolic/ischemic cardiovascular and cerebrovascular diseases, and Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-W014632
CAS No.: 328-90-5
Synonyms: Desacetyl Triflusal
Target:  

Drug Metabolite

Research Areas:  

Others

4-Trifluoromethylsalicylic acid (Desacetyl triflusal) is a platelet aggregation inhibitor .
loading...
    loading...
Cat. No.: HY-W777681
CAS No.: 1276355-35-1
Triflusal-13C6 is a C13-labeled Triflusal. Triflusal is a platelet aggregation inhibitor .
loading...
    loading...
Cat. No.: HY-B0531R
CAS No.: 322-79-2
Triflusal (Standard) is the analytical standard of Triflusal (HY-B0531). This product is intended for research and analytical applications. Triflusal is an orally bioavailable, blood-brain barrier-permeable dual Cyclooxygenase-1 (COX-1)/cAMP phosphodiesterase inhibitor. Triflusal inhibits platelet aggregation, NF-κB activation, iNOS activity, and prostaglandin synthesis in ischaemic tissue. Triflusal stimulates neutrophil nitric oxide production, eNOS protein expression, and cNOS activity. Triflusal alleviates cerebral ischemic injury in rats and ameliorates pathological lesions and related gene expression in transgenic Alzheimer’s disease models. Triflusal can be used for the research of thromboembolic/ischemic cardiovascular and cerebrovascular diseases, and Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-B0531S
CAS No.: 2748541-63-9
Triflusal-d3 is deuterium labeled Triflusal (HY-B0531). Triflusal is an orally bioavailable, blood-brain barrier-permeable dual Cyclooxygenase-1 (COX-1)/cAMP phosphodiesterase inhibitor. Triflusal inhibits platelet aggregation, NF-κB activation, iNOS activity, and prostaglandin synthesis in ischaemic tissue. Triflusal stimulates neutrophil nitric oxide production, eNOS protein expression, and cNOS activity. Triflusal alleviates cerebral ischemic injury in rats and ameliorates pathological lesions and related gene expression in transgenic Alzheimer’s disease models. Triflusal can be used for the research of thromboembolic/ischemic cardiovascular and cerebrovascular diseases, and Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-W014632R
CAS No.: 328-90-5
Synonyms: Desacetyl Triflusal (Standard)
Research Areas:  

Others

4-Trifluoromethylsalicylic acid (Standard) is the analytical standard of 4-Trifluoromethylsalicylic acid. This product is intended for research and analytical applications. 4-Trifluoromethylsalicylic acid (Desacetyl triflusal) is a platelet aggregation inhibitor .
loading...
    loading...
Cat. No.: HY-W014632S
CAS No.: 1246817-12-8
Synonyms: Desacetyl Triflusal-13C6
4-Trifluoromethylsalicylic acid- 13C6 is the 13C labeled 4-Trifluoromethylsalicylic acid . 4-Trifluoromethylsalicylic acid is a platelet aggregation inhibitor .
loading...
    loading...